simultaneous detection of iga/igg antitissue transglutaminase/deamidated gliadin peptides in serodiagnosis of celiac disease
Authors
abstract
background: celiac disease is a common autoimmune disorder that is diagnosed based on clinical case identification, serological screening, and duodenal histology. however, the existence of mild clinical forms, such as seronegative cases with patchy atrophy and potential celiac disease, can make it difficult to determine a definitive diagnosis. the seronegative patients with celiac disease can include those with discordant antibody results and false-negative results, due to unknown origins or selective iga deficiency. case presentation: we present two cases with discordant antibody results in order to evaluate if the simultaneous detection of specific antibodies can improve the serodiagnosis of celiac disease. in both patients, the simultaneous detection of iga/igg anti-tissue transglutaminase/deamidated gliadin peptides gave discordant positive results by the same antibodies assayed individually. conclusion: although further studies are needed to confirm and extend our findings, the simultaneous detection of specific antibodies seems to improve the serodiagnosis of celiac disease in patients with discordant antibody results.
similar resources
Simultaneous Detection of IgA/IgG AntiTissue Transglutaminase/Deamidated Gliadin Peptides in Serodiagnosis of Celiac Disease
Background: Celiac disease is a common autoimmune disorder that is diagnosed based on clinical case identification, serological screening, and duodenal histology. However, the existence of mild clinical forms, such as seronegative cases with patchy atrophy and potential celiac disease, can make it difficult to determine a definitive diagnosis. The seronegative patients with celiac disease can i...
full textCASE REPORT Simultaneous Detection of IgA/IgG Anti- Tissue Transglutaminase/Deamidated Gliadin Peptides inSerodiagnosis of Celiac Disease
Background: Celiac disease is a common autoimmune disorder that is diagnosed based on clinical case identification, serological screening, and duodenal histology. However, the existence of mild clinical forms, such as seronegative cases with patchy atrophy and potential celiac disease, can make it difficult to determine a definitive diagnosis. The seronegative patients with celiac disease can i...
full textAntitissue Transglutaminase IgA for Celiac Disease Testing.
A 23-year-old woman presented for assessment of positive celiac disease serologic testing. The testingwasperformedat thepatient’s requestbecauseher 15-year-oldbrotherwas diagnosed with celiac disease. Based on her test results, the patient was advised to commenceagluten-freediet.However, shebelieved that a small intestinal biopsywouldbeappropriate to confirm her diagnosis and sought another opi...
full textSecretory IgA mediates retrotranscytosis of intact gliadin peptides via the transferrin receptor in celiac disease
Celiac disease (CD) is an enteropathy resulting from an abnormal immune response to gluten-derived peptides in genetically susceptible individuals. This immune response is initiated by intestinal transport of intact peptide 31-49 (p31-49) and 33-mer gliadin peptides through an unknown mechanism. We show that the transferrin receptor CD71 is responsible for apical to basal retrotranscytosis of g...
full textIgG antibodies against deamidated gliadin peptides for diagnosis of celiac disease in patients with IgA deficiency.
BACKGROUND Assays for IgG antibodies against deamidated gliadin (IgG-anti-dGli) are comparable in performance with tests detecting IgA antibodies against tissue transglutaminase (IgA-anti-tTG) in diagnosing celiac disease (CD). IgA-anti-tTG are absent in IgA deficiency, a condition often associated with CD. In IgA deficiency, IgG-anti-tTG, which have a lower overall diagnostic accuracy, are rou...
full textNatural history of antibodies to deamidated gliadin peptides and transglutaminase in early childhood celiac disease.
INTRODUCTION Gliadin proteins play a key role in the pathogenesis of celiac disease; however, as a screen for celiac disease, anti-gliadin antibody testing has been replaced by the more sensitive and specific serological assays for transglutaminase autoantibodies (TGAA). A new generation of anti-gliadin antibody assays has been developed to detect synthetic, deamidated homologous gliadin peptid...
full textMy Resources
Save resource for easier access later
Journal title:
iranian journal of immunologyجلد ۱۲، شماره ۱، صفحات ۷۴-۸۰
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023